Payam Khanlari, Masoud Khosravipour, Faramarz Gharagozlou, Rashid Heidarimoghadam, Mohammad Babamiri ,
Volume 9, Issue 1 (Winter 2020)
Abstract
Background: The prevalence of hypertension (HTN) among Iranian taxi drivers has not been well defined. This study aimed to determine the prevalence of HTN and to identify factors influencing its prevalence among Iranian taxi drivers in 2018.
Materials and Methods: This cross-sectional study was conducted on a total sample of 321 taxi drivers in Kermanshah province in 2018. The participants were classified into two groups, including the HTN group (SBP ≥ 140 or DBP ≥ 90) and the non-HTN group (SBP < 140 or DBP < 90). A self-administrated questionnaire, including questions about demographic information, medical history, and work-related factors was employed to collect data.
Results: According to the observations, 59.8% of the participants (192/321) suffered from HTN. According to the adjusted logistic regression model and the per one unit increase, there was significantly higher odds of HTN for age (odds ratio [OR] =1.04 and 95% confidence interval [CI] =1.02, 1.06) and work history (OR=1.08 and 95% CI=1.03, 1.13); in contrast, there was a lower risk of HTN for sleep duration (OR=0.83 and 95% CI=0.69, 0.99) and Work Days Per Week (WDPW) (OR=0.73 and 95% CI=0.57, 0.94). In the categorical analysis, a significantly higher risk of HTN was observed in the drivers with age ≥ 45, work history ≥ 5, Work Hours Per Day (WHPD) >10, WDPW ≤ 6, married, and poor economic status ≤ a 2-million Toman income per month.
Conclusions: This study introduces taxi drivers as a high-risk HTN group in the society. Hence, they should be informed of HTN risk factors and undergo regular checkups.
Leila Rezakhani, Mozafar Khazaei, Siavash Vaziri, Fatemeh Khosravi Shadmani,
Volume 12, Issue 1 (Winter 2023)
Abstract
Background: Cancer and underlying diseases in the covid-19 pandemic created more problems for those affected by the coronavirus. This study aimed to evaluat patients' mortality and related factors based on underlying diseases in people with COVID-19.
Materials and Methods: This descriptive study was performed on patients with COVID-19 admitted to Kermanshah hospital from February 22, 2020, to September 22, 2021. Clinical information was obtained from medical records and patient's history was extracted from the case documentation. The mortality and case fatality rates in hospitalized COVID-19 cases were calculated. Analysis of logistic regression models was used to identify prognostic factors of death.
Results: Out of 55813 patients admitted to the hospital due to covid-19 on the mentioned date, 4260 died. Furthermore, the most common underlying disease in hospitalized patients due to covid 19 was hypertension (11.4%). The prevalence of cancers was 1.4%. The highest in-hospital case fatality rate was chronic kidney disease (CKD) (21.3%) and cancer (16.6%). In addition, among the underlying diseases, the odds ratio of CKD was 2.12 (CI90%= 1.38- 3.26), and cancers were 2.06 (CI95%= 1.25- 3.37), the most important underlying diseases for odds of death.
Conclusion: The prevalence of hypertension (HTN) and cardiovascular diseases (CVD) was higher in hospitalized patients with COVID-19 than patients with other underlying diseases. However, patients with CKD and cancer had a higher odds ratio for death. Therefore, attention to managing patients with CKD and cancers should be seriously considered and followed.
Masoomeh Ghasemi, Sajad Khosravi, Leila Malekyan, Amin Faridi, Leili Abedi Gheshlaghi, Mohammad Hossein Sobhanipoor, Elham Isaei,
Volume 13, Issue 2 (Spring 2024)
Abstract
Background: Vaccines during the pandemic COVID-19 were the best solution to overcome the pandemic. The aim of this study was to evaluate and compare Sputnik V, Sinopharm, and AstraZeneca vaccins’ side effects.
Material and Methods: A cross-sectional study was designed among healthcare workers in a teaching hospital. The checklist was prepared for collecting data of demographic variables, respondents’ medical history, and vaccines side effects.
Results: More than half of participants received Sinopharm, while the development of COVID-19 following AstraZeneca was significantly among smaller proportion of respondents than other vaccines (P< 0.0001). There was no significant difference between age group and general side effects. The prevalence of serious side effects was higher in healthcare workers younger than 40 years old (P< 0.0001). The emergence of oral side effects was higher in participants who received two doses of vaccines in comparison to individuals who received one dose (P< 0.0001).
Conclusion: The prevalence of serious side effects was higher in sputnik V in comparison to the other vaccines. The vaccines serious side effects were linked to the age of vaccinated people and immune system responses.
Khadijeh Kalan Farmanfarma, Esmaeil Fakharian, Soudabeh Yarmohammadi, Robbert J Gobbens, Zahra Batooli, Fatemeh Sadat Asgarian, Seyed Pouya Taghavi, Motahareh Karimi Houyeh, Fatemeh Sanei, Mehrdad Mahdian, Mohammad Reza Fazel, Gholamreza Reza Khosravi, Masoumeh Abedzadeh- Kalahroudi, Mohammad-Sajjad Lotfi, Reza Fadaei Vatan, Mojtaba Sehat,
Volume 13, Issue 4 (Autumn 2024)
Abstract
Background: Hip fracture, a serious complication of osteoporosis, is associated with high morbidity and mortality rates. Incidence of hip fractures varies among countries worldwide, particularly in individuals aged 50 years and above. This study was conducted to investigate the prevalence and incidence of hip fractures worldwide systematically.
Materials and Methods: This study systematically reviewed English-language articles published between 2002 and 2022. The articles were sourced from internationally recognized databases, including Proquest, Pubmed, Web of Science, and Scopus. The search strategy employed Mesh terms, specifically "Period Prevalence," "Incidence," and "Hip Fracture." The study encompassed cohort, cross-sectional, and case-control studies that reported the prevalence and incidence of hip fractures in populations aged 18 years and above. A total of 40 articles were selected for analysis.
Results: Based on the studies reviewed, Australia had the highest hip fracture prevalence rate (63%), while the United States had the lowest rate (2.3%). In East Asian countries, Japan had an incidence rate of 1.92 per 1000 persons, and Taiwan had a rate of 649 per 100,000 persons.
Conclusion: Hip fracture incidence changes occur in developed and certain Asian countries. A health strategy is needed to identify key factors for fracture prevention and post-fracture care for better outcomes in older individuals.
